冠昊生物(300238.SZ)发布前三季度业绩，归母净利润2671.85万元，下降4.02%

Core Insights - Guanhao Biological (300238.SZ) reported a revenue of 293 million yuan for the first three quarters of 2025, representing a year-on-year growth of 5.52% [1] - The net profit attributable to shareholders of the listed company was 26.7185 million yuan, a decrease of 4.02% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 25.8206 million yuan, showing a year-on-year increase of 27.60% [1] - The basic earnings per share stood at 0.1 yuan [1]